Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 13/20 | 1.00 |
| ▸ | AGXT | P21549 | 4/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | PNMT | P11086 | 2/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30080027 | 1.00 | IDO1 (1.00) | IDO1AGXTCYP3A4PNMTTAAR1 | |
| Hydrochloric Acid SCHEMBL1715800 | 0.98 | IDO1 (1.00) | IDO1AGXTCYP3A4PNMTTAAR1 | |
| SCHEMBL30873130 | 0.81 | IDO1 (0.68) | IDO1PNMTTAAR1NPC1MAPT | |
| SCHEMBL865549 | 0.81 | IDO1 (0.68) | IDO1PNMTTAAR1NPC1MAPT | |
| SCHEMBL1520817 | 0.81 | IDO1 (0.68) | IDO1AGXTCYP3A4 | |
| SCHEMBL24074516 | 0.77 | IDO1 (0.63) | IDO1PNMTTAAR1NPC1MAPT | |
| SCHEMBL791989 | 0.77 | IDO1 (0.63) | IDO1PNMTTAAR1NPC1MAPT | |
| SCHEMBL2093527 | 0.77 | IDO1 (0.63) | IDO1PNMTTAAR1NPC1MAPT | |
| SCHEMBL1859313 | 0.77 | IDO1 (1.00) | IDO1AGXTCYP3A4 | |
| SCHEMBL11023152 | 0.76 | IDO1 (0.61) | IDO1PNMTTAAR1NPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11661436-B2 | Method for preparing 3′-o-amino-2′-deoxyribonucleoside-5′-triphosphates | DNA SCRIPT SAS (FR) | 2023-05-30 | — | — | US | claimed |
| CN-115362161-A | Process for preparing 3' -O-amino-2 ' -deoxyribonucleoside-5 ' -triphosphates | DNA斯克瑞普特公司 | 2022-11-18 | — | — | CN | claimed |
| US-20210300961-A1 | METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES | DNA SCRIPT SAS (FR) | 2021-09-30 | — | — | US | claimed |
| US-11661436-B2 | Method for preparing 3′-o-amino-2′-deoxyribonucleoside-5′-triphosphates | DNA SCRIPT SAS (FR) | 2023-05-30 | — | — | US | disclosed |
| CN-115362161-A | Process for preparing 3' -O-amino-2 ' -deoxyribonucleoside-5 ' -triphosphates | DNA斯克瑞普特公司 | 2022-11-18 | — | — | CN | disclosed |
| US-20210300961-A1 | METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES | DNA SCRIPT SAS (FR) | 2021-09-30 | — | — | US | disclosed |
| US-20160145219-A1 | STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2016-05-26 | — | — | US | disclosed |
| EP-2456782-B1 | 17-HYDROXY-17-PENTAFLUORETHYL-ESTRA-4,9(10)-DIEN-11-BENZYLIDENE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND USE THEREOF FOR TREATING DISEASES | BAYER IP GMBH (DE) | 2015-08-19 | — | — | EP | disclosed |
| EP-2456783-B1 | 17-HYDROXY-17-PENTAFLUORETHYL-ESTRA-4,9(10)-DIEN-11-ETHINYLPHENYL DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND USE THEREOF FOR TREATING DISEASES | BAYER IP GMBH (DE) | 2015-08-19 | — | — | EP | disclosed |
| US-9102701-B2 | 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-ethynylphenyl derivatives, methods for the production thereof and use thereof for treating diseases | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-08-11 | — | — | US | disclosed |
| US-20130289083-A1 | IDO Inhibitors | NEWLINK GENETICS CORPORATION | 2013-10-31 | — | — | US | disclosed |
| US-20060128642-A1 | 9-Ketospinosyn derivatives | BAYER CROPSCIENCE AG (DE) | 2006-06-15 | — | — | US | disclosed |
| EP-1590358-A1 | 9-KETOSPINOSYN DERIVATIVES | Bayer CropScience Aktiengesellschaft (DE) | 2005-11-02 | — | — | EP | disclosed |
| WO-2004065402-A1 | 9-KETOSPINOSYN DERIVATIVES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2004-08-05 | — | — | WO | disclosed |
| EP-0387499-B1 | Substituted oxine ethers and their use as pesticides | BAYER AG (DE) | 1993-12-22 | — | — | EP | disclosed |
| EP-0387499-A2 | Substituted oxine ethers and their use as pesticides | BAYER AG (DE) | 1990-09-19 | — | — | EP | disclosed |
| US-4517183-A | COMBATING DISEASES WITH WEAKNESS OF IMMUNE SYSTEMS | BOEHRINGER MANNHEIM GMBH (DE) | 1985-05-14 | — | — | US | disclosed |
| EP-0014976-B1 | N-SUBSTITUTED 2-CYANAZIRIDINES, METHODS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM, CORRESPONDINGLY SUBSTITUTED AZIRIDINE-2-CARBONAMIDES AND THEIR PREPARATION | Roche Diagnostics GmbH (DE) | 1982-04-07 | — | — | EP | disclosed |
| EP-0015456-B1 | OMEGA-HALOGENO-ACETOPHENONE OXIME ETHERS, PREPARATION THEREOF AND THEIR USE AS INTERMEDIATES IN THE PREPARATION OF OMEGA-AZOLYL-ACETOPHENONE OXIME ETHERS | BAYER AG (DE) | 1981-12-02 | — | — | EP | disclosed |
| US-4293715-A | FUNGICIDES, BACTERICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1981-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210300961-A1 | METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES | DUT, RNMT, NUDT1 | IDO1 997/4885AGXT 971/4885CYP3A4 825/4885 |
| US-20060128642-A1 | 9-Ketospinosyn derivatives | SNX9, NANS, BROX | IDO1 1786/4885AGXT 103/4885CYP3A4 2733/4885 |
| US-11661436-B2 | Method for preparing 3′-o-amino-2′-deoxyribonucleoside-5′-triphosphates | DUT, RNMT, NUDT1 | IDO1 984/4885AGXT 924/4885CYP3A4 879/4885 |
| US-20160145219-A1 | STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI | DPM1, CROCC, SNX1 | IDO1 2645/4885AGXT 485/4885CYP3A4 4336/4885 |
| US-20130289083-A1 | IDO Inhibitors | IDO1, IDO2, INMT | IDO1 1/4885AGXT 285/4885CYP3A4 499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.